Impact of Gender on Clinical Characteristic, Treatment and Outcome in ST Elevation Myocardial Infarction: A Hospital Based Study from North-Eastern India
Farhin Iqbal, B. Dutta, J. C. Barkataki, W. Farooqui, Arun Yadav
{"title":"Impact of Gender on Clinical Characteristic, Treatment and Outcome in ST Elevation Myocardial Infarction: A Hospital Based Study from North-Eastern India","authors":"Farhin Iqbal, B. Dutta, J. C. Barkataki, W. Farooqui, Arun Yadav","doi":"10.31487/j.jicoa.2021.03.06","DOIUrl":null,"url":null,"abstract":"Background: Data on impact of gender on clinical presentation of ST Elevation Myocardial Infarction (STEMI) are sparse in our country. Gender related difference in STEMI has never been studied in North-Eastern India.\nAim: The present study was undertaken to study the impact of gender on clinical characteristic, treatment and outcome in STEMI.\nMethods: We prospectively collected data of 510 STEMI patients from February 2011 to August 2012 in Gauhati Medical College, a tertiary care center in North-Eastern India. We evaluated data on impact of gender in clinical characteristic, treatment, and outcome in STEMI patients.\nResults: A total of 510 cases of STEMI were included. Females in STEMI were older (53.6 years in males compared to 58 years in females, P<0.001) and have greater atypical presentation (31.6% in females and 13.98% in males, P<0.001). Females also have higher mean time to presentation and higher incidence of diabetes, dyslipidemia, hypertension and high BMI, whereas males had higher incidence of smoking. Females are less likely to undergo thrombolysis (28.73% in females compared to 44.34% in males, p=0.04) and revascularization (17.5% in males and 9.1% in females p-0.01) during index hospitalization, but standard medical therapy was similar. Women were also more likely to develop heart failure either at presentation or at 30 days and also had a higher 30-day mortality (15.5% in female and 9.8% in male, p value-0.06).\nConclusion: This study represents the first reported study on impact of gender on clinical presentation of STEMI from North-Eastern India and has observed that females have a higher mean age of presentation, higher incidence of atypical presentation, diabetes, dyslipidemia, hypertension and high BMI. Females also present later than males, though statistically not significant and also less likely to receive thrombolysis and revascularization than males. The 30-day mortality was also higher in females.","PeriodicalId":93027,"journal":{"name":"Journal of integrative cardiology open access","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of integrative cardiology open access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/j.jicoa.2021.03.06","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Data on impact of gender on clinical presentation of ST Elevation Myocardial Infarction (STEMI) are sparse in our country. Gender related difference in STEMI has never been studied in North-Eastern India.
Aim: The present study was undertaken to study the impact of gender on clinical characteristic, treatment and outcome in STEMI.
Methods: We prospectively collected data of 510 STEMI patients from February 2011 to August 2012 in Gauhati Medical College, a tertiary care center in North-Eastern India. We evaluated data on impact of gender in clinical characteristic, treatment, and outcome in STEMI patients.
Results: A total of 510 cases of STEMI were included. Females in STEMI were older (53.6 years in males compared to 58 years in females, P<0.001) and have greater atypical presentation (31.6% in females and 13.98% in males, P<0.001). Females also have higher mean time to presentation and higher incidence of diabetes, dyslipidemia, hypertension and high BMI, whereas males had higher incidence of smoking. Females are less likely to undergo thrombolysis (28.73% in females compared to 44.34% in males, p=0.04) and revascularization (17.5% in males and 9.1% in females p-0.01) during index hospitalization, but standard medical therapy was similar. Women were also more likely to develop heart failure either at presentation or at 30 days and also had a higher 30-day mortality (15.5% in female and 9.8% in male, p value-0.06).
Conclusion: This study represents the first reported study on impact of gender on clinical presentation of STEMI from North-Eastern India and has observed that females have a higher mean age of presentation, higher incidence of atypical presentation, diabetes, dyslipidemia, hypertension and high BMI. Females also present later than males, though statistically not significant and also less likely to receive thrombolysis and revascularization than males. The 30-day mortality was also higher in females.
背景:在我国,性别对ST段抬高型心肌梗死(STEMI)临床表现影响的数据较少。STEMI的性别相关差异从未在印度东北部进行过研究。目的:本研究旨在探讨性别对STEMI患者临床特征、治疗及转归的影响。方法:前瞻性收集2011年2月至2012年8月印度东北部高哈蒂医学院(Gauhati Medical College)三级医疗中心510例STEMI患者的资料。我们评估了性别对STEMI患者临床特征、治疗和结局的影响。结果:共纳入STEMI 510例。STEMI患者的女性年龄较大(男性为53.6岁,女性为58岁,P<0.001),非典型表现较多(女性为31.6%,男性为13.98%,P<0.001)。女性的平均发病时间也更长,糖尿病、血脂异常、高血压和高BMI的发病率也更高,而男性的吸烟率更高。在指数住院期间,女性接受溶栓(女性为28.73%,男性为44.34%,p=0.04)和血运重建术(男性为17.5%,女性为9.1%,p= 0.01)的可能性较低,但标准药物治疗相似。女性在就诊时或30天内更容易发生心力衰竭,30天死亡率也更高(女性为15.5%,男性为9.8%,p值为0.06)。结论:本研究首次报道了性别对印度东北部STEMI临床表现的影响,并观察到女性的平均表现年龄更高,非典型表现、糖尿病、血脂异常、高血压和高BMI的发生率更高。女性出现的时间也比男性晚,但在统计上不显著,而且接受溶栓和血运重建术的可能性也比男性低。女性的30天死亡率也更高。